Effects of canagliflozin on cardiovascular disease risk factors in patients with type 2 diabetes: a systematic review and meta-analysis

Effects of canagliflozin on cardiovascular disease risk factors in patients with type 2 diabetes: a systematic review and meta-analysis

Abstract Background Canagliflozin or sodium-glucose co-transporter 2 inhibitor (SGLT2i) is considered as an authorized therapeutic drug for treatment of patients with type 2 diabetes mellitus (T2DM). This study reviews and evaluates the effects of Canagliflozin on Hemoglobin (HbA1c), Body Mass Index...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hossein Aftabi, Reyhaneh Aftabi
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	BMC Endocrine Disorders
Subjects:	Canagliflozin Type 2 diabetes mellitus Cardiovascular disease Hemoglobin level Body mass index Systolic blood pressure
Online Access:	https://doi.org/10.1186/s12902-025-01984-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of canagliflozin combined with alfacalcidol in the treatment of elderly type 2 diabetes mellitus with osteoporosis
by: HUANG Yi*，JIANGXiong，PENG Jun，GUI Xiao，LIU Shuang，LI Peng，LI Yanling，JIANG Meiling
Published: (2025-07-01)

Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board
by: M. V. Shestakova, et al.
Published: (2022-01-01)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
by: A. V. Simanenkova, et al.
Published: (2021-07-01)

Canagliflozin protects cardiovascular function in type 2 diabetic coronary artery disease by regulating natriuretic peptide B
by: Jiarui Zhang, et al.
Published: (2025-08-01)

An Observational Study on the Effect of Canagliflozin on Left Ventricular Diastolic Function in Patients with Type 2 Diabetes Mellitus in a Tertiary Care Hospital of West Bengal
by: Kalyan Kumar Das, et al.
Published: (2024-12-01)

Canagliflozin Pharmacokinetics at Steady State in Patients on Maintenance Hemodialysis
by: Thomas A. Mavrakanas, et al.
Published: (2024-10-01)

The Impact of Serum Ghrelin on Body Mass Index in Children with Type1 Diabetes Mellitus
by: Safa A. Ayash, et al.
Published: (2025-04-01)

The role of canagliflozin in the prevention of stroke and chronic kidney disease in patients with type 2 diabetes mellitus: an expert council resolution
by: M. V. Shestakova, et al.
Published: (2023-11-01)

Canagliflozin‐induced renal glutathione distribution mapping in non‐diabetic male rat kidneys
by: Guy Watanabe, et al.
Published: (2025-04-01)

The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity
by: Tatiana Palotta Minari, et al.
Published: (2024-10-01)

Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation
by: N. A. Avxentyev, et al.
Published: (2022-10-01)

Estimation of Apelin Levels in Iraqi Patients with Type II Diabetic Peripheral Neuropathy
by: Hadel Khalid Jaid, et al.
Published: (2023-10-01)

Possibilities of telemedicine influence on the level of systolic blood pressure in patients with diabetes mellitus in combination with arterial hypertension
by: F. F. Hajiyeva, et al.
Published: (2023-01-01)

Criterion validity of metabolic and anthropometric predictors in diabetic foot syndrome
by: Bubanja Dragana, et al.
Published: (2019-01-01)

The Correlation Between Body Weight and Arterial Blood Pressure in 11 and 15 Years Old Children: Retrospective Cross-Sectional Study
by: Ksenia A. Eletskaya, et al.
Published: (2019-12-01)

Association between blood hemoglobin levels, anemia, and body mass index in children and women of Myanmar: findings from a nationally representative health study
by: Shiva Raj Acharya, et al.
Published: (2024-12-01)

Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers, Combined with Dapagliflozin as Type 2 Diabetes Mellitus Routine Treatment: A Controlled Randomized, Double-blind Trial
by: Walid Aburayyan, et al.
Published: (2025-05-01)

The Effect of a Nutrition Education Program on Improving Hemoglobin A1c and Body Mass Index of Patients with Type 2 Diabetes Mellitus in Erbil City: A Non-randomized Clinical Trial
by: Hawraz F. Saadi, et al.
Published: (2020-06-01)

Body weight and waist circumference as predictors of vitamin D deficiency in patients with type 2 diabetes and cardiovascular disease
by: Kavarić Sreten, et al.
Published: (2013-01-01)

Association between body mass index and diabetes mellitus control classification among patients with type 2 diabetes mellitus: Evidence from the National Diabetes Registry of Muar District Health Office, Malaysia, from January 2021 to July 2023
by: Muhammad Muzzammil Mohamad Salleh, et al.
Published: (2025-04-01)

Decreased peroxidase activity of glycated hemoglobin inversely correlated with levels of glycated hemoglobin in type 2 diabetes patients
by: Pinaki Saha, et al.
Published: (2023-03-01)

The relationship of body mass index with fasting blood glucose in type-2 diabetes mellitus
by: Rimadhani Ervina Tria, et al.
Published: (2024-01-01)

Commentary: Effect of probiotics at different intervention time on glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
by: Shanshan Wu, et al.
Published: (2025-03-01)

Parental imprisonment, childhood behavioral problems, and adolescent and young adult cardiometabolic risk: results from a prospective Australian birth cohort study
by: Michael E. Roettger, et al.
Published: (2025-04-01)

A validated multivariable machine learning model to predict cardio-kidney risk in diabetic kidney disease
by: James L. Jr. Januzzi, et al.
Published: (2025-05-01)

Effect of group-based nutritional education combined with individual standard care for outpatients with type 2 diabetes: study protocol for a randomized clinical trial {1}
by: Aline Busanello, et al.
Published: (2025-03-01)

Cardiovascular Risk Factors as Independent Predictors of Diabetic Retinopathy in Type II Diabetes Mellitus: The Development of a Predictive Model
by: Cristian Dan Roşu, et al.
Published: (2024-10-01)

Blood pressure in children and adolescents with type 1 diabetes mellitus - the influence of body mass index and fat mass
by: Wojciech Młynarski, et al.
Published: (2009-12-01)

Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study)
by: Mohammad Saifuddin, et al.
Published: (2024-11-01)

Kepatuhan minum obat hipoglikemik oral dan indeks massa tubuh terhadap kadar gula darah pada pasien diabetes melitus tipe 2
by: Ika Hanna Nurul Wathani, et al.
Published: (2024-10-01)

Effectiveness of Dapagliflozin in Treating Type 2 Diabetes Mellitus in a Real-World Indian Setting
by: Uday M. Jadhav, et al.
Published: (2025-04-01)

Formulation and Evaluation of Canagliflozin Self-nanomicellizing Solid Dispersion Based on Rebaudioside A for Dissolution and Solubility Improvement
by: Nizar Awish Jassem, et al.
Published: (2025-02-01)

New opportunities for the correction of type 2 diabetes mellitus in patients with liver diseases
by: L. Yu. Morgunov, et al.
Published: (2022-01-01)

Serum Homocysteine Levels and Blood Pressure in Type 2 Diabetic Patients in Zaria, Northern Nigeria.
by: Lawal, N.* , Akuyam, S.A. , Anaja, P.O. ,Bakari, A.G. , Ahmad, M.B.
Published: (2022-08-01)

Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
by: Vladimir Ivanovich Kudinov, et al.
Published: (2011-06-01)

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT
by: Srinivasan Beddhu, et al.
Published: (2018-09-01)

Case of type 1 diabetes mellitus with decreased hemoglobin glycation index after switching insulin pump
by: Momoka Hasegawa, et al.
Published: (2025-07-01)

Association Between Alcohol Consumption and the Risk of Type 2 Diabetes Mellitus Across Different Body Mass Index Categories Among Japanese Workers
by: Yu Wang, et al.
Published: (2025-08-01)

The relationship between hypertension, anemia, and BMI in women of reproductive age: evidence from a nationwide health study
by: Shiva Raj Acharya, et al.
Published: (2025-07-01)

Glycated Hemoglobin Level and Body Mass Index Correlation with Peripheral Artery Disease in Patients with Type 2 Diabetes Mellitus at Waled Hospital, Cirebon, Indonesia
by: Tania Auliya, et al.
Published: (2024-12-01)